| |
| Magyar Dermatológiai Társulat |
|
| GERDA 2021 - 42nd Cours du GERDA |
 Rendezvény kezdete: 2021.09.23. | Rendezvény vége: 2021.09.24. |
| Munkahely neve: c/o MCI France |
| Címe: 25 rue Anatole France – CS70139
92532 Levallois-Perret Cedex, France |
| Tel: + 33 (0) 1 53 85 82 51 |
| E-mail: info@gerda2021.com |
| Helyszín: France, Nantes, |
| A rendezvény Web oldala: https://www.gerda2021.com/ |
The 42nd Cours du GERDA will take place on the 23rd and 24th of September 2021 in Nantes, France.
GERDA 2021 is the place for exchanges, discoveries and teaching. This year, attendees will discover new allergens, and answers will be given to their many questions in technological, immunological, pharmacological, therapeutic and cosmetology fields. The preliminary programme is available on the congress website: www.gerda2021.com
GERDA in figures:
· + 500 dermatology experts
· + 30 exhibitors
· + 10 scientifics sessions
· + 40 speakers
· Around 80 submitted abstracts
DATES IMPORTANTES
17 FÉVRIER 2021
Ouverture des inscriptions
17 FÉVRIER 2021
Ouverture de la soumission des résumés
|
|
|
 |
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
